Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 75, Issue 2, 2007, Pages 246-248

  Hashemi, Mohammad ^a   Naderi, Mohammad ^b   Rashidi, Homaira ^c   Ghavami, Saeid ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; IDDM; NIDDM; s TIC; Serum trypsin inhibitory capacity

Indexed keywords

ALPHA 1 ANTITRYPSIN; GLUCOSE; TRYPSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASSAY; BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLYCOSYLATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SERUM;

ADULT; AGED; ALPHA 1-ANTITRYPSIN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 33845395329     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.06.020     Document Type: Article

References (11)

1. Perlmutter D.H. Alpha-1-antitrypsin deficiency: diagnosis and treatment. Clin. Liver Dis. 8 (2004) 839-859
2. Ghavami S., Hashemi M., Shahriari H.A., Bajestani S.N., de Serres F.J., Moghaddam E., et al. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran. Clin. Biochem. 38 (2005) 425-432
3. Hashemi M., Alavian S.M., Ghavami S., de Serres F.J., Salehi M., Doroudi T., et al. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol. Res. 33 (2005) 292-297
4. Dietz A.A., Rubinstein H.M., and Hodges L.K. Measurment of alpha 1 antitrypsin in serum, by immunodiffusion and enzymatic assay. Clin. Chem. Lab. Med. 20 (1974) 396-399
5. Piwowar A., Knapik-Kordecka M., and Warwas M. Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes. Clin. Chem. Lab. Med. 38 (2000) 1257-1261
6. Ganrot P.O., Gydell K., and Ekelund H. Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus. Acta Endocrinol. (Copenh.) 55 (1967) 537-544
7. Phadke M., Billimoria F.R., and Ninjoor V. Non enzymatic glycosylation of alpha-1-proteinase inhibitor of human plasma. J. Postgrad. Med. 44 (1998) 29-34
8. Roberts R.C., Hall P.K., Nikolai T.F., and McKenzie A.K. Reduced trypsin binding capacity of alpha 2-macroglobulin in diabetes. Clin. Chim. Acta 154 (1986) 85-101
9. Bidasee K.R., Nallani K., Yu Y., Cocklin R.R., Zhang Y., Wang M., Dincer U.D., and Besch H.R. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 52 (2003) 1825-1836
10. Duell P.B., Oram J.F., and Bierman E.L. Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes 39 (1990) 1257-1263
11. Travis J., and Salvesen G.S. Human plasma proteinase inhibitors. Ann. Rev. Biochem. 52 (1983) 655-709